Who owns BIODEXA PHARMACEUTICALS PLC?
- Ticker: BDRX
- CUSIP Number: 59564r708
Tip: Access positions for across all investors
Analyze quarterly positions in Biodexa Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Biodexa Pharmaceuticals stock
Who bought or sold BIODEXA PHARMACEUTICALS PLC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Two Sigma Securities | 21k | $18k | 100% | Jun 2024 |
|
| Rhumbline Advisers | 6.0k | $1.7k | 123% | Sep 2024 |
|
| Contravisory Investment Management | 1.0k | $282.000000 | 0% | Sep 2024 |
|
| GAMMA Investing | 287.00 | $80.991400 | -93% | Sep 2024 |
|
| Morgan Stanley | 16.00 | $14.000000 | 0% | Jun 2024 |
|
Who sold out of Biodexa Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Virtu Financial | Jun 2024 | 36k | $32k |
| Citadel Advisors | Jun 2024 | 33k | $30k |
| Susquehanna International | Jun 2024 | 30k | $27k |
| Ground Swell Capital | Jun 2024 | 13k | $12k |
| Bank of America Corporation | Jun 2024 | 859.00 | $768.976800 |